25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Remedent Inc
Buy, Hold or Sell?

Let's analyze Remedent together

I guess you are interested in Remedent Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Remedent Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Remedent Inc

I send you an email if I find something interesting about Remedent Inc.

1. Quick Overview

1.1. Quick analysis of Remedent (30 sec.)










1.2. What can you expect buying and holding a share of Remedent? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.12
Expected worth in 1 year
$0.07
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.06
Return On Investment
-114.5%

For what price can you sell your share?

Current Price per Share
$0.05
Expected price per share
$0.05 - $0.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Remedent (5 min.)




Live pricePrice per Share (EOD)
$0.05
Intrinsic Value Per Share
$-0.13 - $0.09
Total Value Per Share
$0.00 - $0.21

2.2. Growth of Remedent (5 min.)




Is Remedent growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4m$2.7m-$286.1k-11.7%

How much money is Remedent making?

Current yearPrevious yearGrowGrow %
Making money-$274.4k-$1.4m$1.2m444.7%
Net Profit Margin-27.8%-173.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Remedent (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Remedent?

Welcome investor! Remedent's management wants to use your money to grow the business. In return you get a share of Remedent.

First you should know what it really means to hold a share of Remedent. And how you can make/lose money.

Speculation

The Price per Share of Remedent is $0.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Remedent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Remedent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.12. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Remedent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-27.5%-0.01-27.5%-0.07-149.5%-0.03-50.3%0.008.0%
Usd Book Value Change Per Share-0.01-28.6%-0.01-28.6%-0.08-169.5%-0.03-64.9%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-28.6%-0.01-28.6%-0.08-169.5%-0.03-64.9%0.000.3%
Usd Price Per Share0.07-0.07-0.17-0.16-0.18-
Price to Earnings Ratio-5.10--5.10--2.27-84.08-41.86-
Price-to-Total Gains Ratio-4.89--4.89--2.01--9.64--2.19-
Price to Book Ratio0.57-0.57-1.24-0.83-1.16-
Price-to-Total Gains Ratio-4.89--4.89--2.01--9.64--2.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.05
Number of shares20000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.03
Usd Total Gains Per Share-0.01-0.03
Gains per Quarter (20000 shares)-286.20-649.07
Gains per Year (20000 shares)-1,144.81-2,596.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1145-11550-2596-2606
20-2290-23000-5193-5202
30-3434-34450-7789-7798
40-4579-45900-10385-10394
50-5724-57350-12981-12990
60-6869-68800-15578-15586
70-8014-80250-18174-18182
80-9159-91700-20770-20778
90-10303-103150-23366-23374
100-11448-114600-25963-25970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%8.017.00.032.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%11.012.02.044.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%4.06.00.040.0%11.012.02.044.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Remedent Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.014-0.0140%-0.085+492%-0.032+127%0.000-9044%
Book Value Per Share--0.1220.1220%0.137-10%0.190-36%0.180-32%
Current Ratio--0.3320.3320%0.323+3%0.295+12%0.504-34%
Debt To Asset Ratio--0.5540.5540%0.511+8%0.444+25%0.447+24%
Debt To Equity Ratio--1.3311.3310%1.101+21%0.872+53%0.923+44%
Dividend Per Share----0%-0%-0%-0%
Eps---0.014-0.0140%-0.075+445%-0.025+83%0.004-442%
Free Cash Flow Per Share---0.007-0.0070%-0.003-58%-0.003-61%0.009-173%
Free Cash Flow To Equity Per Share---0.007-0.0070%-0.003-58%-0.003-61%-0.003-48%
Gross Profit Margin--1.0001.0000%1.0000%1.094-9%1.589-37%
Intrinsic Value_10Y_max--0.090--------
Intrinsic Value_10Y_min---0.126--------
Intrinsic Value_1Y_max--0.009--------
Intrinsic Value_1Y_min---0.008--------
Intrinsic Value_3Y_max--0.027--------
Intrinsic Value_3Y_min---0.028--------
Intrinsic Value_5Y_max--0.045--------
Intrinsic Value_5Y_min---0.052--------
Market Cap999800.000-40%1399720.0001399720.0000%3399320.000-59%3119376.000-55%3579284.000-61%
Net Profit Margin---0.278-0.2780%-1.730+522%-0.630+127%-0.140-50%
Operating Margin---0.125-0.1250%-0.328+163%-0.142+14%-0.065-48%
Operating Ratio--1.1251.1250%1.328-15%1.142-1%1.169-4%
Pb Ratio0.408-40%0.5720.5720%1.243-54%0.831-31%1.160-51%
Pe Ratio-3.643+29%-5.100-5.1000%-2.274-55%84.083-106%41.862-112%
Price Per Share0.050-40%0.0700.0700%0.170-59%0.156-55%0.179-61%
Price To Free Cash Flow Ratio-7.661+29%-10.725-10.7250%-61.458+473%412.142-103%246.604-104%
Price To Total Gains Ratio-3.494+29%-4.892-4.8920%-2.006-59%-9.640+97%-2.191-55%
Quick Ratio--0.3000.3000%0.290+3%0.251+20%0.401-25%
Return On Assets---0.050-0.0500%-0.267+435%-0.098+96%-0.001-99%
Return On Equity---0.120-0.1200%-0.577+380%-0.197+64%-0.021-83%
Total Gains Per Share---0.014-0.0140%-0.085+492%-0.032+127%0.000-9044%
Usd Book Value--2448720.0002448720.0000%2734866.000-10%3808913.963-36%3605865.678-32%
Usd Book Value Change Per Share---0.014-0.0140%-0.085+492%-0.032+127%0.000-9044%
Usd Book Value Per Share--0.1220.1220%0.137-10%0.190-36%0.180-32%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.014-0.0140%-0.075+445%-0.025+83%0.004-442%
Usd Free Cash Flow---130512.000-130512.0000%-55311.638-58%-50854.858-61%178369.153-173%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.003-58%-0.003-61%0.009-173%
Usd Free Cash Flow To Equity Per Share---0.007-0.0070%-0.003-58%-0.003-61%-0.003-48%
Usd Market Cap999800.000-40%1399720.0001399720.0000%3399320.000-59%3119376.000-55%3579284.000-61%
Usd Price Per Share0.050-40%0.0700.0700%0.170-59%0.156-55%0.179-61%
Usd Profit---274446.000-274446.0000%-1494837.000+445%-619523.594+126%22130.545-1340%
Usd Revenue--986220.000986220.0000%863819.000+14%1099961.762-10%1909608.842-48%
Usd Total Gains Per Share---0.014-0.0140%-0.085+492%-0.032+127%0.000-9044%
 EOD+3 -5MRQTTM+0 -0YOY+18 -155Y+19 -1510Y+5 -29

3.3 Fundamental Score

Let's check the fundamental score of Remedent Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.643
Price to Book Ratio (EOD)Between0-10.408
Net Profit Margin (MRQ)Greater than0-0.278
Operating Margin (MRQ)Greater than0-0.125
Quick Ratio (MRQ)Greater than10.300
Current Ratio (MRQ)Greater than10.332
Debt to Asset Ratio (MRQ)Less than10.554
Debt to Equity Ratio (MRQ)Less than11.331
Return on Equity (MRQ)Greater than0.15-0.120
Return on Assets (MRQ)Greater than0.05-0.050
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Remedent Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.030
Ma 20Greater thanMa 500.050
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.056
OpenGreater thanClose0.050
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Remedent Inc

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

Fundamental data was last updated by Penke on 2024-11-06 17:15:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Remedent earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -27.8% means that $-0.28 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Remedent Inc:

  • The MRQ is -27.8%. The company is making a huge loss. -2
  • The TTM is -27.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-27.8%TTM-27.8%0.0%
TTM-27.8%YOY-173.0%+145.2%
TTM-27.8%5Y-63.0%+35.2%
5Y-63.0%10Y-14.0%-49.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.8%6.3%-34.1%
TTM-27.8%4.8%-32.6%
YOY-173.0%7.3%-180.3%
5Y-63.0%7.0%-70.0%
10Y-14.0%7.4%-21.4%
4.3.1.2. Return on Assets

Shows how efficient Remedent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • -5.0% Return on Assets means that Remedent generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Remedent Inc:

  • The MRQ is -5.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.0%TTM-5.0%0.0%
TTM-5.0%YOY-26.7%+21.7%
TTM-5.0%5Y-9.8%+4.8%
5Y-9.8%10Y-0.1%-9.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.0%0.9%-5.9%
TTM-5.0%0.8%-5.8%
YOY-26.7%1.5%-28.2%
5Y-9.8%1.6%-11.4%
10Y-0.1%1.6%-1.7%
4.3.1.3. Return on Equity

Shows how efficient Remedent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • -12.0% Return on Equity means Remedent generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Remedent Inc:

  • The MRQ is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM-12.0%0.0%
TTM-12.0%YOY-57.7%+45.6%
TTM-12.0%5Y-19.7%+7.7%
5Y-19.7%10Y-2.1%-17.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%1.9%-13.9%
TTM-12.0%1.4%-13.4%
YOY-57.7%2.7%-60.4%
5Y-19.7%3.2%-22.9%
10Y-2.1%3.0%-5.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Remedent Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Remedent is operating .

  • Measures how much profit Remedent makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -12.5% means the company generated $-0.12  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Remedent Inc:

  • The MRQ is -12.5%. The company is operating very inefficient. -2
  • The TTM is -12.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-12.5%TTM-12.5%0.0%
TTM-12.5%YOY-32.8%+20.3%
TTM-12.5%5Y-14.2%+1.7%
5Y-14.2%10Y-6.5%-7.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.5%6.9%-19.4%
TTM-12.5%5.2%-17.7%
YOY-32.8%10.7%-43.5%
5Y-14.2%9.6%-23.8%
10Y-6.5%9.1%-15.6%
4.3.2.2. Operating Ratio

Measures how efficient Remedent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.12 means that the operating costs are $1.12 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Remedent Inc:

  • The MRQ is 1.125. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.125. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.125TTM1.1250.000
TTM1.125YOY1.328-0.203
TTM1.1255Y1.142-0.017
5Y1.14210Y1.169-0.027
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1251.055+0.070
TTM1.1251.056+0.069
YOY1.3281.017+0.311
5Y1.1421.049+0.093
10Y1.1691.012+0.157
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Remedent Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Remedent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.33 means the company has $0.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Remedent Inc:

  • The MRQ is 0.332. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.332. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.332TTM0.3320.000
TTM0.332YOY0.323+0.009
TTM0.3325Y0.295+0.036
5Y0.29510Y0.504-0.208
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3322.119-1.787
TTM0.3322.320-1.988
YOY0.3232.494-2.171
5Y0.2952.649-2.354
10Y0.5042.654-2.150
4.4.3.2. Quick Ratio

Measures if Remedent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.30 means the company can pay off $0.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Remedent Inc:

  • The MRQ is 0.300. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.300. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.300TTM0.3000.000
TTM0.300YOY0.290+0.010
TTM0.3005Y0.251+0.049
5Y0.25110Y0.401-0.151
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3001.076-0.776
TTM0.3001.212-0.912
YOY0.2901.241-0.951
5Y0.2511.482-1.231
10Y0.4011.640-1.239
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Remedent Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Remedent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Remedent to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.55 means that Remedent assets are financed with 55.4% credit (debt) and the remaining percentage (100% - 55.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Remedent Inc:

  • The MRQ is 0.554. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.554. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.554TTM0.5540.000
TTM0.554YOY0.511+0.043
TTM0.5545Y0.444+0.110
5Y0.44410Y0.447-0.003
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5540.370+0.184
TTM0.5540.360+0.194
YOY0.5110.345+0.166
5Y0.4440.365+0.079
10Y0.4470.376+0.071
4.5.4.2. Debt to Equity Ratio

Measures if Remedent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 133.1% means that company has $1.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Remedent Inc:

  • The MRQ is 1.331. The company is able to pay all its debts with equity. +1
  • The TTM is 1.331. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.331TTM1.3310.000
TTM1.331YOY1.101+0.231
TTM1.3315Y0.872+0.460
5Y0.87210Y0.923-0.052
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3310.554+0.777
TTM1.3310.563+0.768
YOY1.1010.532+0.569
5Y0.8720.599+0.273
10Y0.9230.655+0.268
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Remedent generates.

  • Above 15 is considered overpriced but always compare Remedent to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -5.10 means the investor is paying $-5.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Remedent Inc:

  • The EOD is -3.643. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.100. Based on the earnings, the company is expensive. -2
  • The TTM is -5.100. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.643MRQ-5.100+1.457
MRQ-5.100TTM-5.1000.000
TTM-5.100YOY-2.274-2.826
TTM-5.1005Y84.083-89.184
5Y84.08310Y41.862+42.222
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-3.64316.228-19.871
MRQ-5.10015.980-21.080
TTM-5.10015.924-21.024
YOY-2.27419.454-21.728
5Y84.08321.787+62.296
10Y41.86224.302+17.560
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Remedent Inc:

  • The EOD is -7.661. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.725. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.725. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.661MRQ-10.725+3.064
MRQ-10.725TTM-10.7250.000
TTM-10.725YOY-61.458+50.733
TTM-10.7255Y412.142-422.867
5Y412.14210Y246.604+165.538
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-7.66113.670-21.331
MRQ-10.72513.684-24.409
TTM-10.7259.200-19.925
YOY-61.458-0.685-60.773
5Y412.1420.909+411.233
10Y246.604-1.494+248.098
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Remedent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 0.57 means the investor is paying $0.57 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Remedent Inc:

  • The EOD is 0.408. Based on the equity, the company is cheap. +2
  • The MRQ is 0.572. Based on the equity, the company is cheap. +2
  • The TTM is 0.572. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.408MRQ0.572-0.163
MRQ0.572TTM0.5720.000
TTM0.572YOY1.243-0.671
TTM0.5725Y0.831-0.259
5Y0.83110Y1.160-0.330
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.4082.492-2.084
MRQ0.5722.609-2.037
TTM0.5722.771-2.199
YOY1.2432.724-1.481
5Y0.8313.882-3.051
10Y1.1604.419-3.259
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets5,489
Total Liabilities3,040
Total Stockholder Equity2,284
 As reported
Total Liabilities 3,040
Total Stockholder Equity+ 2,284
Total Assets = 5,489

Assets

Total Assets5,489
Total Current Assets1,008
Long-term Assets4,481
Total Current Assets
Cash And Cash Equivalents 43
Net Receivables 869
Inventory 92
Other Current Assets 4
Total Current Assets  (as reported)1,008
Total Current Assets  (calculated)1,008
+/-0
Long-term Assets
Property Plant Equipment 21
Long-term Assets  (as reported)4,481
Long-term Assets  (calculated)21
+/- 4,460

Liabilities & Shareholders' Equity

Total Current Liabilities3,040
Long-term Liabilities0
Total Stockholder Equity2,284
Total Current Liabilities
Short-term Debt 15
Accounts payable 2,342
Other Current Liabilities 539
Total Current Liabilities  (as reported)3,040
Total Current Liabilities  (calculated)2,896
+/- 144
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock20
Retained Earnings -20,765
Accumulated Other Comprehensive Income -1,046
Other Stockholders Equity 24,075
Total Stockholder Equity (as reported)2,284
Total Stockholder Equity (calculated)2,284
+/-0
Other
Cash and Short Term Investments 43
Common Stock Shares Outstanding 19,996
Current Deferred Revenue144
Liabilities and Stockholders Equity 5,489
Net Debt -43
Net Working Capital -2,032



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
0
0
785,545
517
2,165
2,713
5,063
4,378
7,446
10,202
7,935
9,622
6,965
6,527
6,168
5,545
5,703
4,730
5,438
7,896
7,509
7,182
6,948
5,588
5,489
5,4895,5886,9487,1827,5097,8965,4384,7305,7035,5456,1686,5276,9659,6227,93510,2027,4464,3785,0632,7132,165517785,54500
   > Total Current Assets 
0
0
395,032
471
2,121
2,565
4,579
3,652
5,962
8,264
4,503
7,354
3,269
2,571
3,441
2,907
2,859
1,285
1,671
656
681
575
1,017
922
1,008
1,0089221,0175756816561,6711,2852,8592,9073,4412,5713,2697,3544,5038,2645,9623,6524,5792,5652,121471395,03200
       Cash And Cash Equivalents 
0
0
31,940
0
1
40
332
127
1,728
1,807
613
1,663
204
65
775
399
94
147
93
67
115
78
174
105
43
4310517478115679314794399775652041,6636131,8071,728127332401031,94000
       Short-term Investments 
0
0
0
0
172
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001720000
       Net Receivables 
0
0
117,274
315
1,496
1,644
2,371
1,724
1,903
3,208
807
2,765
838
948
1,938
1,997
2,136
943
1,159
234
329
386
746
722
869
8697227463863292341,1599432,1361,9971,9389488382,7658073,2081,9031,7242,3711,6441,496315117,27400
       Other Current Assets 
0
0
148,272
39
22
322
406
668
970
1,311
920
763
1,149
567
129
96
218
84
295
245
146
8
3
2
4
423814624529584218961295671,1497639201,3119706684063222239148,27200
   > Long-term Assets 
0
0
390,513
46
44
147
484
726
1,483
1,938
3,432
2,268
3,696
3,956
2,728
2,638
2,844
3,445
3,767
7,240
6,828
6,607
5,931
4,666
4,481
4,4814,6665,9316,6076,8287,2403,7673,4452,8442,6382,7283,9563,6962,2683,4321,9381,4837264841474446390,51300
       Property Plant Equipment 
0
0
60,502
44
44
86
317
590
693
1,025
1,736
1,402
641
695
489
435
411
274
144
126
67
68
68
41
21
21416868671261442744114354896956411,4021,7361,02569359031786444460,50200
       Goodwill 
0
0
330,011
0
0
0
0
0
0
0
700
700
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000007007000000000330,01100
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,219
2,196
2,433
3,171
3,624
7,115
6,761
0
0
0
0
00006,7617,1153,6243,1712,4332,1962,21900000000000000
       Intangible Assets 
0
0
0
0
0
62
166
136
116
163
247
167
0
0
20
7
0
0
0
0
0
58
37
21
0
021375800000720001672471631161361666200000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000
> Total Liabilities 
0
0
1,516,336
1,703
2,319
1,808
3,106
3,642
3,732
3,868
4,009
6,590
5,060
5,040
3,850
3,442
3,433
1,552
2,126
2,433
2,888
2,754
2,698
2,854
3,040
3,0402,8542,6982,7542,8882,4332,1261,5523,4333,4423,8505,0405,0606,5904,0093,8683,7323,6423,1061,8082,3191,7031,516,33600
   > Total Current Liabilities 
0
0
1,516,336
1,703
2,319
1,808
3,045
3,490
3,638
3,767
3,583
6,316
3,607
3,909
3,850
3,442
3,433
1,552
2,126
2,433
2,882
2,754
2,698
2,854
3,040
3,0402,8542,6982,7542,8822,4332,1261,5523,4333,4423,8503,9093,6076,3163,5833,7673,6383,4903,0451,8082,3191,7031,516,33600
       Short-term Debt 
0
0
371
363
431
294
708
1,585
838
739
890
2,745
1,943
2,051
2,531
2,172
2,222
5
231
51
131
5
22
40
15
15402251315123152,2222,1722,5312,0511,9432,7458907398381,58570829443136337100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,531
2,172
2,222
0
52
0
0
0
0
0
0
0000005202,2222,1722,53100000000000000
       Accounts payable 
0
0
310,163
453
668
890
1,632
1,442
2,002
1,398
1,933
1,744
1,009
972
599
847
789
1,039
1,569
1,919
2,295
2,241
2,137
2,176
2,342
2,3422,1762,1372,2412,2951,9191,5691,0397898475999721,0091,7441,9331,3982,0021,4421,632890668453310,16300
       Other Current Liabilities 
0
0
1,205,802
887
1,221
605
704
463
797
1,590
760
1,352
598
737
596
335
348
436
244
399
356
397
429
470
539
5394704293973563992444363483355967375981,3527601,5907974637046051,2218871,205,80200
   > Long-term Liabilities 
0
0
0
0
0
0
61
152
95
101
426
274
1,453
1,131
0
71
87
69
80
71
5
0
0
0
0
00005718069877101,1311,4532744261019515261000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
14
0
0
00145500000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
0
0
0
0
00004600000000000000000000
> Total Stockholder Equity
0
0
-728,292
-1,186
-858
-274
1,957
736
3,713
5,438
3,812
2,194
1,888
1,469
2,319
2,032
2,183
3,108
3,231
5,392
4,547
4,335
4,112
2,593
2,284
2,2842,5934,1124,3354,5475,3923,2313,1082,1832,0322,3191,4691,8882,1943,8125,4383,7137361,957-274-858-1,186-728,29200
   Common Stock
0
0
30,824
31
40
2
13
13
19
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
202020202020202020202020202020201913132403130,82400
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
455
-70
61
-28
-33
28
-641
-650
-835
-1,682
-1,118
-793
-1,185
-1,195
-1,114
-937
-985
-1,070
-1,022
-987
-1,012
-1,046
-1,046-1,012-987-1,022-1,070-985-937-1,114-1,195-1,185-793-1,118-1,682-835-650-64128-33-2861-70455000
   Capital Surplus 0000000000000000000000000
   Treasury Stock000000-831-831-831-831-83100000000000000
   Other Stockholders Equity 
0
0
-754,445
4,005
4,881
5,427
11,624
11,904
17,930
23,275
24,008
24,122
24,172
24,172
24,172
24,172
24,172
24,172
24,172
24,075
24,172
24,075
24,075
24,075
24,075
24,07524,07524,07524,07524,17224,07524,17224,17224,17224,17224,17224,17224,17224,12224,00823,27517,93011,90411,6245,4274,8814,005-754,44500



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue986
Cost of Revenue-383
Gross Profit603603
 
Operating Income (+$)
Gross Profit603
Operating Expense-726
Operating Income-123-123
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense7260
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-123
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-235-11
EBIT - interestExpense = -123
-258
-274
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-123-235
Earnings Before Interest and Taxes (EBITDA)-103
 
After tax Income (+$)
Income Before Tax-235
Tax Provision-0
Net Income From Continuing Ops0-235
Net Income-274
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,109
Total Other Income/Expenses Net-1120
 

Technical Analysis of Remedent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Remedent. The general trend of Remedent is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Remedent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Remedent Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.05 < 0.05 < 0.05.

The bearish price targets are: 0.05 > 0.05 > 0.05.

Tweet this
Remedent Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Remedent Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Remedent Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Remedent Inc. The current macd is -0.00030788.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Remedent price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Remedent. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Remedent price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Remedent Inc Daily Moving Average Convergence/Divergence (MACD) ChartRemedent Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Remedent Inc. The current adx is 59.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Remedent shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Remedent Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Remedent Inc. The current sar is 0.05286036.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Remedent Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Remedent Inc. The current rsi is 0.03049567. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Remedent Inc Daily Relative Strength Index (RSI) ChartRemedent Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Remedent Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Remedent price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Remedent Inc Daily Stochastic Oscillator ChartRemedent Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Remedent Inc. The current cci is -66.66666667.

Remedent Inc Daily Commodity Channel Index (CCI) ChartRemedent Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Remedent Inc. The current cmo is -99.99978982.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Remedent Inc Daily Chande Momentum Oscillator (CMO) ChartRemedent Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Remedent Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Remedent Inc Daily Williams %R ChartRemedent Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Remedent Inc.

Remedent Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Remedent Inc. The current atr is 0.000035.

Remedent Inc Daily Average True Range (ATR) ChartRemedent Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Remedent Inc. The current obv is -408,000.

Remedent Inc Daily On-Balance Volume (OBV) ChartRemedent Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Remedent Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Remedent Inc Daily Money Flow Index (MFI) ChartRemedent Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Remedent Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Remedent Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Remedent Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.030
Ma 20Greater thanMa 500.050
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.056
OpenGreater thanClose0.050
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Remedent with someone you think should read this too:
  • Are you bullish or bearish on Remedent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Remedent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Remedent Inc

I send you an email if I find something interesting about Remedent Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Remedent Inc.

Receive notifications about Remedent Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.